top of page
84770f_68a07779fe514e93b3876e8ff37f34c4~mv2.png

What's New

84770f_68a07779fe514e93b3876e8ff37f34c4~mv2.png

Subscribe for Exclusive Early Bird Access

Smart Parking Ltd

Endeavor Asset Management

  • Endeavor Asset Management identifies Smart Parking Systems as a top pick for the next three to six months.
  • Analysts project a revenue growth of 25% and a shift to profitability by next June.
  • Earnings before interest, taxes, depreciation, and amortisation margins are expected to expand from 10% to 15%.
  • The stock trades at approximately eight times forward EV/EBITDA, significantly below its historical average of 12 times.
  • The global smart-parking market is anticipated to reach $US10 billion by 2028, presenting growth opportunities.
  • Smart Parking's expansion in the USA offers clear catalysts for future growth.
  • Compared to peers trading at 14 times EV/EBITDA, there is notable re-rating potential with new contract announcements.

ASX:SPZ

$0.79

Clarity Pharmaceuticals Ltd

Frazis Capital Partners

  • Frazis Capital Partners observes that Clarity Pharmaceuticals is affected by broader sell-offs in the biotech sector, particularly following negative results from Opthea.
  • Liquidations by funds and retail investors have increased due to market momentum unwinding.
  • Clarity has substantial growth potential with approximately $20 billion in diagnostics and even larger opportunities in therapeutics.
  • The company's current market cap of $400 million significantly underplays its potential against the market opportunity.
  • Short selling has created liquidity and potential for future funding, however, it poses risks for shortsellers as momentum can reverse.
  • With $106 million in cash and an $11 million non-dilutive R&D grant, Clarity is well-positioned to extend its development timeline.
  • Positive clinical updates include improved patient outcomes and ongoing trials that could validate Clarity's treatments.
  • Noteworthy therapeutic data includes disease control rates of 78% in patients who had previously undergone multiple treatments.
  • Clarity's diagnostic agent shows promise, having identified lesions better than standard diagnostics and may lead to significant treatment changes.
  • Upcoming clinical trial readouts over the next year are expected to enhance clarity on Clarity's market position.
  • Both diagnostics and therapeutics markets show potential—diagnostics forecasted at $3 billion and therapeutics exceeding $5 billion.
  • Frazis Capital Partners recently reinstated a holding in Clarity, now constituting ~8% of their portfolio, indicating confidence in the company's future growth.

ASX:CU6

$2.08

Paladin Energy Ltd

Blackwattle Investment Partners

  • Paladin Energy experienced a drop of 25.7% in March due to a significant flood event at its Langer Heinrich mine.
  • The extent of damage from the flood has been clarified, with production impacted for a limited number of weeks.
  • Delays in reaching nameplate capacity have pushed out timelines, which is viewed as a critical milestone.
  • Continued softness in the spot price and market uncertainty have contributed to ongoing declines in Paladin's share price.
  • Blackwattle Investment Partners has reduced the position size while awaiting further clarity from management on the ramp-up timeline.
  • Investors can expect commentary on these issues during the March quarterly investor call later this month.

ASX:PDN

$5.11

Genesis Minerals Ltd

Blackwattle Investment Partners

  • Genesis Minerals rose +16.7% in the month.
  • Astute M&A in 2022-23 laid the foundations for impressive growth.
  • Laverton mill restarted and ramped up to nameplate capacity.
  • Production set to climb from 50koz today to 135koz by FY29.
  • Genesis has a fully funded 10-year plan to produce 3 million ounces of gold.
  • 91% of ounces already in reserve provides a high level of certainty.
  • Assets like the Westralia pit not yet included in mine plan.
  • A fantastic team demonstrates passion, focus, and owner mentality.

ASX:GMD

$3.71

James Hardie Industries plc

Ten Cap

  • James Hardie Industries (JHX) was the portfolio’s most significant contributor during the period.
  • Ten Cap had a short position in JHX, based on a cautious stance regarding US housing.
  • This stance was informed by a combination of industry feedback and macroeconomic data indicating endmarket weakness.
  • Concerns were heightened by JHX's announcement of its acquisition of AZEK, a US-based decking business.
  • The size of the transaction was unanticipated by Ten Cap.
  • Ten Cap's positioning was influenced by observable signals such as the suspension of the share buyback program.
  • There was also a noted increase in M&A-related recruitment activity.

ASX:JHX

$38.48

Move Logistics Group Ltd

Naos Asset Management

  • Naos Asset Management views MOV's recent results as exceeding expectations after a challenging period with leadership changes.
  • Despite a ~5% year-on-year revenue decline, MOV saw a ~6% revenue increase from 2HFY24 driven by a revamped sales team.
  • Gross margin improved significantly, rising by ~14% year-on-year and reaching ~5.2%, indicating better sales margins.
  • The company reported a normalized EBT loss of ~$3.9 million, an improvement from previous losses.
  • Strong business momentum continues, with the strongest quarterly performance in 18 months.
  • Guidance for profitability in FY26 was reaffirmed, necessitating run-rate profitability by May/June.
  • Expected factors for profitability include:
    • Further gross margin improvements from utilization benefits and price increases.
    • Reduction in underutilized leased property in warehousing.
    • Increased benefits from the 'Accelerate Program' in 2HFY25.
    • Aiming for an additional $4 million annualized fixed cost reduction.
    • Improvement in retail sector volumes expected to enhance MOV's profitability.
  • MOV is demonstrating characteristics seen in previous high-performing investments, such as:
    • Customer-first approach with high service levels.
    • Value-based pricing strategy.
    • Building an experienced and aligned team.
    • Clear market offering that resonates with customers.
    • Cost-efficient operations with minimal waste.
  • With a NZD $300 million revenue base, even modest margin improvements can significantly benefit shareholders.
  • Current market capitalization of $25 million NZD suggests minimal margin expectations, presenting potential for growth.

ASX:MOV

Unknown

Hancock & Gore Ltd

Naos Asset Management

  • Naos Asset Management notes that HNG has put forward an all-scrip acquisition proposal for H&G High Conviction Limited (ASX: HCF).
  • HNG is related to HCF as its manager and substantial shareholder.
  • The acquisition is expected to complete during Q4 FY25.
  • Acquiring HCF provides funding for Remaining Deferred Consideration related to the Schoolblazer Ltd. acquisition.
  • The HCF assets, being liquid, add optionality to HNG's balance sheet for settling deferred considerations.
  • Simplification of HNG's business is necessary for shareholders to realize full value; acquiring HCF is a step towards this.
  • This move may pave the way for Global Uniforms Solutions to potentially operate as a standalone entity.
  • HNG aims for a larger & more liquid listed entity by acquiring HCF, enhancing market capitalization and trading activity.
  • Many top holders of HNG are directors, aligning their interests but potentially reducing share trading activity.

ASX:HNG

$0.27

Solvar Ltd

Endeavor Asset Management

  • Endeavor Asset Management notes that shares in car financier Solvar (SVR) have remained stable despite market softness.
  • The company has continued its on-market buyback program, which has positively impacted the share price.
  • Solvar is currently trading at just 8x FY26e earnings.
  • The stock offers a fully franked yield of 9.2%, indicating attractive pricing.
  • Recent strength in the stock led Endeavor Asset Management to trim their position.

ASX:SVR

$1.44

James Hardie Industries plc

Bennelong Long Short Equity Fund

  • James Hardie announced the acquisition of Azek, a synthetic/composite decking supplier in the US known as TimberTech.
  • Bennelong Long Short Equity Fund notes that James Hardie achieves excellent returns and growth from its legacy fibre cement business, dominating the fibre cement segment with a 90% market share.
  • High returns, along with high organic growth and dominant market share, are rare attributes for businesses.
  • Despite Azek's rapid growth, it operates in a more competitive segment, with lower returns than James Hardie.
  • The fund believes that JHX's agreement to pay a high price for Azek dilutes the quality of their core business.
  • This dilution creates a poor risk/reward trade-off for JHX shareholders.
  • The market has reacted negatively to this acquisition, punishing JHX's stock for the perceived risks involved.

ASX:JHX

$38.48

Motio Ltd

Mereweather Capital

  • Mereweather Capital has initiated a position in Motio (MXO) due to short-term market volatility presenting unique opportunities.
  • MXO operates as a digital place-based media business with over 1600 digital screens across various sectors such as medical centres and sports venues.
  • The majority of MXO's screen network was established through four acquisitions since 2019, totaling approximately $6m.
  • Post-acquisition, efforts were needed to refresh assets and engage customers, with a focus on enhancing advertisement utilisation.
  • Management indicated that the bulk of foundational work is complete, shifting focus to monetising their network in FY25.
  • MXO has consistently upgraded its FY25 financial guidance, from $7.7m revenue and $800k cash EBITDA to $8.6m revenue and $1.2m cash EBITDA.
  • Management improved the balance sheet through divesting a non-core software asset, generating $1.35m cash and $1.4m free cashflow.
  • Mereweather Capital views MXO’s cash generation as substantially stronger than reported profits, due to non-cash expenses affecting financial statements.
  • MXO currently has an $8m market capitalisation and approximately $1.5m in net cash.
  • Despite potential 2H uncertainty due to the Federal election, the seasonality trend suggests stronger performance in 2H for MXO.
  • This investment aligns with Mereweather Capital’s strategy of targeting neglected micro and nano cap stocks.
  • MXO management is experienced, with CEO Adam Cadwallader having nearly 25 years in the industry and ownership aligning with minority shareholders.
  • The business model is capital light and generates high cash flow, operating in areas of structural growth despite traditional media weaknesses.

ASX:MXO

$0.03

Subscribe

Join the email list for updates.

Thanks for submitting!

Thesis-Tracker.com aggregates insights from financial services professionals exclusively for informational and educational purposes. Thesis-Tracker.com does not publish proprietary opinions nor does Thesis-Tracker.com enter into commercial arrangements with any of the featured financial services professionals. Before making a decision please consider these and any relevant Product Disclosure Statement. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs.

bottom of page